The next steps and updated guidelines for the use of MRD concepts in multiple myeloma
Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax
Daratumumab in multiple myeloma: an overview of 3 key trials
Niels van de Donk
Lenalidomide maintenance – an active approach to treating MM?
Recently approved drugs for the treatment of multiple myeloma